Literature DB >> 19911148

Risk factors and laser therapy for retinopathy of prematurity in neonatal intensive care unit.

Li Liu1, Tian Tian, Chong-Xun Zheng, Vatavu Ileana, Anca Ioana, Ciomartan Tatiana, Racovitan Oana.   

Abstract

BACKGROUND: With the increasing survival rates of preterm infants, the incidence of retinopathy of prematurity (ROP) is also increasing. This study aimed to investigate the risk factors for ROP in Neonatal Intensive Care Unit, and the effects of laser therapy.
METHODS: Thirty-five premature infants with various other diseases were studied. Data were collected including gender, gestational age, birth weight, maternal gravidity, Apgar score, antenatal and postnatal hypoxia, anemia, jaundice, infection, pregnancy complications, and head ultrasound manifestations. All patients were subjected to fundus examinations at a postmenstrual age of 34 weeks using an indirect ophthalmoscope. The infants were divided into ROP group and non-ROP group. Infants with ROP received laser treatment. The data of the infants were analyzed using univariate analysis and the logistic regression model.
RESULTS: Twenty-seven (77.1%) of the 35 infants had ROP and 21 of them also had plus diseases. The recovery rates were 74.1% and 92.6% at 2 weeks and 3 months after laser therapy, respectively. The birth weight and gestational age in the ROP group were significantly lower than those in the non-ROP group (P<0.01). The lower the gestational age and birth weight, the higher the incidence of ROP. There was a significant difference in the incidence of ROP with postnatal hypoxia (P=0.013), anemia (P=0.012) and gravidity two (P<0.05), analyzed with the Fisher's exact probability test (P<0.05). The gestational age was significantly lower in the plus disease group than in the non-plus disease group (P<0.05).
CONCLUSIONS: The incidence of ROP is high in premature infants with various other diseases and is correlated with birth weight, gestational age, postnatal hypoxia, anemia and maternal gravidity. Laser therapy shows good outcomes.

Entities:  

Mesh:

Year:  2009        PMID: 19911148     DOI: 10.1007/s12519-009-0058-6

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  16 in total

1.  Diode laser photocoagulation to the ridge and avascular retina in threshold retinopathy of prematurity.

Authors:  Robert L Steinmetz; H Logan Brooks
Journal:  Retina       Date:  2002-02       Impact factor: 4.256

2.  [The analysis of failure diode laser treatment of active phase of retinopathy of prematurity].

Authors:  Anna Gotz-Wieckowska; Małgorzata Rydlewska-Fojut; Agnieszka Siennicka; Ewa Burchardt-Kroll; Janusz Gadzinowski
Journal:  Klin Oczna       Date:  2006

3.  An international classification of retinopathy of prematurity. The Committee for the Classification of Retinopathy of Prematurity.

Authors: 
Journal:  Arch Ophthalmol       Date:  1984-08

4.  The effect of anemia on retinopathy of prematurity in extremely low birth weight infants.

Authors:  J A Englert; R A Saunders; D Purohit; T C Hulsey; M Ebeling
Journal:  J Perinatol       Date:  2001 Jan-Feb       Impact factor: 2.521

5.  Outcomes after laser therapy for threshold retinopathy of prematurity.

Authors:  R Foroozan; B P Connolly; W S Tasman
Journal:  Ophthalmology       Date:  2001-09       Impact factor: 12.079

Review 6.  Retinopathy of prematurity.

Authors:  D L Phelps
Journal:  Pediatr Rev       Date:  1995-02

7.  [Retinopathy of prematurity: risk factors analysis].

Authors:  Ewa Ortyl; Ryszard Lauterbach; Maria Starzycka
Journal:  Przegl Lek       Date:  2002

8.  Incidence of retinopathy of prematurity from 1996 to 2000: analysis of a comprehensive New York state patient database.

Authors:  Michael F Chiang; Raymond R Arons; John T Flynn; Justin B Starren
Journal:  Ophthalmology       Date:  2004-07       Impact factor: 12.079

9.  [Retinopathy in premature infants].

Authors:  N E Schalij-Delfos; J U M Termote; B P Cats
Journal:  Ned Tijdschr Geneeskd       Date:  2002-05-25

10.  An assessment tool for screening ROP in the preterm infant.

Authors:  Dawn N Birdsell
Journal:  Insight       Date:  2002 Oct-Dec       Impact factor: 0.878

View more
  2 in total

Review 1.  Retinopathy of prematurity: a review of risk factors and their clinical significance.

Authors:  Sang Jin Kim; Alexander D Port; Ryan Swan; J Peter Campbell; R V Paul Chan; Michael F Chiang
Journal:  Surv Ophthalmol       Date:  2018-04-19       Impact factor: 6.048

2.  Intravitreal Ranibizumab Injection for the Treatment of Retinopathy of Prematurity.

Authors:  Tariq Aldebasi; Muataz A Guma; Rabia Bashir; Saif Al Saif; Waleed A Altwaijri; Abdulkareem M Al Bekairy
Journal:  Med Princ Pract       Date:  2019-04-16       Impact factor: 1.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.